Funds holding Maze Therapeutics Inc
ISIN US5787841007 · United States
- Fund holders
- 145
- Of which ETFs
- 35 110 other funds
- Value held
- 169.2M $
- Share of capital
- 9.1 % of 55.5M shares on Aug 5, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 1,551 | 46.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 1,359 | 62K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust | 1,350 | 40.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 1,328 | 60.5K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 1,324 | 60.4K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Responsible U.S. Equity ETF American Century ETF Trust | 1,183 | 53.9K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 1,096 | 32.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Putnam Multi-Asset Income Fund Putnam Asset Allocation Funds | 1,082 | 49.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 1,000 | 29.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell Investments U.S. Small Cap Equity ETF Russell Investments Exchange Traded Funds | 975 | 29.1K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 931 | 42.4K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 929 | 42.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Eventide Small Cap ETF Strategy Shares | 925 | 24.6K $ | 0.10 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 892 | 23.7K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 880 | 23.4K $ | 0.69 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 852 | 25.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Franklin Allocation Moderately Aggressive Portfolio SEASONS SERIES TRUST | 783 | 23.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 777 | 23.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 776 | 20.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 700 | 20.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 655 | 19.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 628 | 18.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Putnam VT Global Asset Allocation Fund Putnam Variable Trust | 500 | 14.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 479 | 21.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 368 | 11K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 365 | 9.7K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 314 | 9.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 303 | 9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 298 | 7.9K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 266 | 7.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 200 | 5.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 198 | 5.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 184 | 5.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 159 | 4.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 130 | 3.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 109 | 2.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 88 | 2.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 67 | 2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 60 | 1.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 48 | 1.3K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 37 | 1.1K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 36 | 1.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 22 | 1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 7 | 319.1 $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 7 | 209 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.42 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.13 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.09 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 0.71 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 0.69 % | as of Apr 30, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 0.51 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.51 % | as of Apr 30, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 0.50 % | as of Feb 28, 2026 ↗ |
| Carillon Chartwell Small Cap Fund Carillon Series Trust | 0.45 % | as of Mar 31, 2026 ↗ |
| Carillon Chartwell Small Cap Growth Fund Carillon Series Trust | 0.43 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 145 | +18 | 5,059,540 | +6.9 % |
| 2026Q1 | 127 | +30 | 4,731,308 | +57.4 % |
| 2025Q4 | 97 | +21 | 3,005,541 | +94.9 % |
| 2025Q3 | 76 | +18 | 1,541,893 | -26.4 % |
| 2025Q2 | 58 | 2,095,982 |
Institutional managers
160 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 4,567,274 | 136.3M $ | as of Mar 31, 2026 |
| TRV GP IV, LLC | 4,473,958 | 133.5M $ | as of Mar 31, 2026 |
| ARCH Venture Management, LLC | 4,120,053 | 123M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 3,477,562 | 103.8M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,858,876 | 85.3M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 2,744,399 | 81.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,570,425 | 76.7M $ | as of Mar 31, 2026 |
| a16z Capital Management, L.L.C. | 1,702,225 | 50.8M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 1,602,034 | 47.8M $ | as of Mar 31, 2026 |
| Alphabet Inc. | 1,388,583 | 41.4M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 1,235,000 | 36.9M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,178,000 | 35.2M $ | as of Mar 31, 2026 |
| General Catalyst Group Management, LLC | 1,035,910 | 30.9M $ | as of Mar 31, 2026 |
| TRV GP V, LLC | 950,800 | 28.4M $ | as of Mar 31, 2026 |
| FMR LLC | 864,214 | 25.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 775,714 | 23.2M $ | as of Mar 31, 2026 |
| ArrowMark Colorado Holdings LLC | 767,383 | 22.9M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 758,857 | 22.7M $ | as of Mar 31, 2026 |
| Cormorant Asset Management, LP | 750,000 | 22.4M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 650,229 | 19.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 636,722 | 19M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 636,162 | 19M $ | as of Mar 31, 2026 |
| Caligan Partners LP | 614,962 | 18.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 599,967 | 17.9M $ | as of Mar 31, 2026 |
| BESSEMER GROUP INC | 481,790 | 14.4K $ | as of Mar 31, 2026 |
Declared shareholders of Maze Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Paradigm BioCapital Advisors LP and 3 others | 6.10 % | 3,051,087 | as of Mar 25, 2026 · SCHEDULE 13G |
| JANUS HENDERSON GROUP PLC | 5.80 % | 2,858,876 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Maze Therapeutics Inc". https://titelia.com/en/stocks/maze-therapeutics-inc-US5787841007